CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 133 enrolled
Drug / intervention
PockeTalker +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03594500
NCT03594500N/ACompleted
CompareCT.gov

Hearing Impairment, Strategies, and Outcomes in Emergency Departments

VA Office of Research and Development·interventional·Posted Jul 20, 2018·Updated Nov 5, 2025

In Brief

A clinical study evaluating PockeTalker and No PockeTalker for Hearing Loss and 2 related conditions. Completed, enrolled 133 participants across 1 site.

Detailed Summary

Aim 1: Establish the feasibility of screening for hearing loss in the ED Aim 2: Determine the acceptability of the screening procedure (among the ED population) Aim 3: Derive a preliminary estimate of the effect size of primary outcomes Aim 4: Identify the evidence that decision makers in Veteran Affair Medical Centers, ED and Audiology Services need to commit to this approach

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss, Emergency Service, Hospital Readmission
CountriesUnited States
CollaboratorsNYU Langone Health

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 20, 2018
Enrollment StartMar 18, 2019
Primary CompletionNov 26, 2019
Study CompletionJan 2, 2020
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 8.0 years ago

Interventions

PockeTalkerother

The intervention group will receive PockeTalkers (hearing assistance devices) while they receive care in the ED

No PockeTalkerother

The control group will not receive PockeTalkers while they receive care in the ED